3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Small Cell Lung Carcinoma
13
Burkitt Lymphoma
9
Lung Neoplasms
7
Lymphoma, Non-Hodgkin
6
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
5
Leukemia, Myeloid, Acute
5
Carcinoma, Non-Small-Cell Lung
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Lymphoma, Large B-Cell, Diffuse
4
Lymphoma
4
Hodgkin Disease
4
Sarcoma, Ewing
3
Recurrence
3
Plasmablastic Lymphoma
3
Multiple Myeloma
3
Lymphoma, B-Cell
3
Leukemia
3
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Neoplasms, Plasma Cell
2
Neoplasms
2
Myelodysplastic Syndromes
2
Lymphoproliferative Disorders
2
Lymphoma, T-Cell
2
Lymphoma, Mantle-Cell
2
Lymphoma, Follicular
2
Immunoblastic Lymphadenopathy
2
HIV Infections
2
Ganglioneuroblastoma
2
Congenital Abnormalities
2
Central Nervous System Neoplasms
2
Interventions
pembrolizumab
15
Cisplatin
7
Cetuximab
5
dostarlimab
3
Surveys and Questionnaires
3
Carboplatin
3
fludarabine
2
abemaciclib
2
Standard of Care
2
Radiotherapy, Intensity-Modulated
2
Paclitaxel
2
Nivolumab
2
Interviews as Topic
2
Fulvestrant
2
Docetaxel
2
Cyclophosphamide
2
Blood Specimen Collection
2
130-nm albumin-bound paclitaxel
2
ulixertinib
1
trastuzumab deruxtecan
1
toripalimab
1
tislelizumab
1
ribociclib
1
repotrectinib
1
patritumab deruxtecan
1
palbociclib
1
osimertinib
1
olaparib
1
niraparib
1
nimotuzumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Head and Neck Neoplasms
×
Etoposide
×
30 days
×
Clear all
No trials found.